The recipient of an MBA in finance from Roosevelt University, John Klein is an Alpine, NJ-based pharmaceutical executive who concurrently serves as chairman of Cambridge Therapeutics and chairman and CEO of Bi-Logix, LLC. With the latter company, New Jersey’s John Klein coordinates marketing efforts for the enterprise performance management (EPM) firm’s copyrighted methodology to support improved business functions.
EPM is a corporate process that aims to set strategy and ensure its execution via the optimization of budgets and financial reporting. It functions under the assumption that a company’s products and services are also made in an efficient and cost-saving manner. However, this isn’t always the case. To ensure maximum efficiency, companies should employ both EPM and Six Sigma processes.
A data-driven methodology that aims to eliminate defects in transactional and manufacturing processes, Six Sigma was developed by William Deming for use in the Japanese manufacturing industry following WWII, and has since been employed by major US corporations such as Honeywell, Motorola, and Ritz Carlton Hotels.
Once a business establishes its desired strategy using EPM, Six Sigma principles should be employed to eliminate waste and inefficiencies from operation processes. These principles include emphasis on the customer, utilization of data, and continuous improvement.